Protalix BioTherapeutics (PLX) Q2 2026 Earnings

May 13Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.05
0.04
0.13
0.22

Details

Expected EPS
-0.01
Actual EPS
0.22
Surprise EPS
0.23
Surprise Percent
+2,300%

Description

⁨Protalix BioTherapeutics⁩ (⁦PLX⁩) has reported earnings of ⁦0.22⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts